Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cyberattack will leave lasting reputational damage to London Drugs

Jim Wilkie Jim Wilkie, The Market Online
0 Comments| May 1, 2024

{{labelSign}}  Favorites
{{errorMessage}}

This week’s “cybersecurity incident” that forced London Drugs to close all its stores across Western Canada is another harsh reminder of the vulnerabilities all companies face in the digital age.

For decades, information security mainly operated in the shadows of organizations, a misunderstood skillset often left to its own devices. Now, however, companies are more at risk to data breaches as business operations have increasingly shifted online, from customer and vendor transactions, sales tracking and compensation figures, to name a few.

The closing of more than 80 London Drugs stores since Sunday was reminiscent of cyberattacks in recent years that struck Capital One (NYSE:COF), Equifax’s (NYSE:EFX), Indigo (TSE:IDG), Norsk Hydro (OTCMKTS:NHYDY) and JPMorgan Chase (NYSE:JPM).

Back in November, in a Public Pulse feature you can watch in the video above, The Market Online’s Ryan Dhillon examined the impact security breaches had on the reputations and performance of those companies.

Join the discussion: Find out what everybody’s saying about public companies and hot topics about stocks at Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.




{{labelSign}}  Favorites
{{errorMessage}}